asdsada
  • Home
  • Our Service
    • Screening of the active ingredient(s) of plants
    • Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins.
    • Establishment of analysis methods of active ingredient(s)
    • Manufacture process study for active ingredient(s)
    • Manufacture process study for finished products
    • Toxicity Studies (LD50, Acute, Chronic, Geno)
    • In Vitro Test /Research Service
    • Animal study
    • Clinic study (Phase1 – Phase 4)
    • Natural Formulation Research Service
    • Contract manufacture (OEM) for active ingredient
    • Contract manufacture (OEM) for finished products
  • Products
    • Ready to go formulation
      • Cardiology
      • Brain
      • Neurology
      • Gynecolgy
      • Nephrology
      • Cardiovascular
      • Dermatology
      • Endocrinology
      • Respiratory
      • Gastroenterology
      • Rheumatology
      • Immunology
      • Hepatology
      • Infectious diseases
      • Internal Medicine
      • Ophthalmology
      • Oral medicine
      • Otolaryngology
      • Pediatrics
      • Psychiatry
      • Stomatology
      • Surgery
      • Urology
      • Vascular Surgery
    • New Medicines
    • Ready To Go Single Herb Extract
  • About Us
    • About Yineng
    • Our Vision
    • Our Honors
    • Our Scientists
    • Our Customers
  • News
  • Contact Us
English
  • 中文
    • Home
    • What we do
    • Clinic study

    Categories

    • Active ingredients screening
    • Evaluation for natural matrials
    • Analysis method establishing
    • Manufacture process study for active ingredient(s)
    • Manufacture process study for finished products
    • Toxicity studies
    • In Vitro Test
    • Animal study
    • Clinic study
    • Natural formulation study
    • OEM for ingredients
    • OEM for finished products

    Featured Services

    • Screening of the active ingredient(s) of plants
      Screening of the active ingredient(s) of plants
    • Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins.
      Study and evaluation of the potency of the botanical...
    • Establishment of analysis methods of active ingredient(s)
      Establishment of analysis methods of active ingredie...
    • Manufacture process study for active ingredient(s)
      Manufacture process study for active ingredient(s)
    • Manufacture process study for finished products
      Manufacture process study for finished products
    • Toxicity Studies (LD50, Acute, Chronic, Geno)
      Toxicity Studies (LD50, Acute, Chronic, Geno)
    • Animal study
      Animal study
    • In Vitro Test /Research Service
      In Vitro Test /Research Service
    • Clinic study (Phase1 – Phase 4)
      Clinic study (Phase1 – Phase 4)
    • Natural Formulation Research Service
      Natural Formulation Research Service
    • Contract manufacture (OEM) for active ingredient
      Contract manufacture (OEM) for active ingredient
    • Contract manufacture (OEM) for finished products
      Contract manufacture (OEM) for finished products

    Clinic study

    • Clinic study (Phase1 – Phase 4)

      Clinic study (Phase1 – Phase 4)

      Under contract research for new active ingredient or new formula, we can arrange clinic study, according to the requirement, including human trail in small group for dietary supplements, as well as phase I, phase II, phase III and phase IV clinic study which is required by new drug application requirements, to support our customers to get necessary data and be qualified for new drug application (NDA).

      inquirydetail
    asdsada

    © Copyright - 2010-2025: All Rights Reserved.
    Sitemap - AMP Mobile
    Cdmo, Toxicity Study, Contract Manufacture, Human Trial, Manufacture Process Study, Cro,

    • twitter
    • facebook
    • linkedin

    Contact us

    • YINENG PHARMA
    • Room 101, Building 1, No. 31 Qianfutang Road, Dongfanghong Subdistrict, Yuelu District, Changsha City, Hunan Province, China
    • ynswyy@163.com

    Latest News

    • Good News| MedGence was approved to establish Hunan Provincial Engineering and Technology Research Center
      27/12/23

      Good News| MedGence was approved to esta...

    • Cooperation Agreement – MedGence debuted at the Hunan Biomedical and Health Industry Expo and signed a cooperation agreement to jointly build the National Children’s Medical Center (Sha...
      01/12/23

      Cooperation Agreement – MedGence de...

    • Several leaders of MedGence won the honor of “2022-2023 Excellent Management Talents of Pharmaceutical Enterprises” in the second Mount Taishan Pharmaceutical Forum
      11/11/23

      Several leaders of MedGence won the honor...

    Online Inquiry
  • Send Email
  • x
    Hit enter to search or ESC to close
    • English
    • French
    • German
    • Portuguese
    • Spanish
    • Russian
    • Japanese
    • Korean
    • Arabic
    • Irish
    • Greek
    • Turkish
    • Italian
    • Danish
    • Romanian
    • Indonesian
    • Czech
    • Afrikaans
    • Swedish
    • Polish
    • Basque
    • Catalan
    • Esperanto
    • Hindi
    • Lao
    • Albanian
    • Amharic
    • Armenian
    • Azerbaijani
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Cebuano
    • Chichewa
    • Corsican
    • Croatian
    • Dutch
    • Estonian
    • Filipino
    • Finnish
    • Frisian
    • Galician
    • Georgian
    • Gujarati
    • Haitian
    • Hausa
    • Hawaiian
    • Hebrew
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Kurdish
    • Kyrgyz
    • Latin
    • Latvian
    • Lithuanian
    • Luxembou..
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Burmese
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Punjabi
    • Serbian
    • Sesotho
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Samoan
    • Scots Gaelic
    • Shona
    • Sindhi
    • Sundanese
    • Swahili
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu
    • Kinyarwanda
    • Tatar
    • Oriya
    • Turkmen
    • Uyghur